Citigroup’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$94.7K Buy
23,672
+22,151
+1,456% +$88.6K ﹤0.01% 3703
2025
Q1
$4.84K Sell
1,521
-46,701
-97% -$149K ﹤0.01% 4496
2024
Q4
$258K Sell
48,222
-74,636
-61% -$399K ﹤0.01% 3429
2024
Q3
$649K Buy
+122,858
New +$649K ﹤0.01% 2834
2022
Q4
Sell
-526
Closed 4958
2022
Q3
$0 Sell
526
-158
-23% ﹤0.01% 5024
2022
Q2
$1K Sell
684
-1,358
-67% -$1.99K ﹤0.01% 5186
2022
Q1
$3K Buy
2,042
+639
+46% +$939 ﹤0.01% 5125
2021
Q4
$3K Buy
1,403
+1,376
+5,096% +$2.94K ﹤0.01% 4925
2021
Q3
$0 Hold
27
﹤0.01% 5057
2021
Q2
$0 Hold
27
﹤0.01% 5453
2021
Q1
$0 Hold
27
﹤0.01% 5505
2020
Q4
$0 Hold
27
﹤0.01% 5197
2020
Q3
$0 Hold
27
﹤0.01% 5046
2020
Q2
$0 Sell
27
-1,780
-99% ﹤0.01% 5057
2020
Q1
$4K Buy
1,807
+1,780
+6,593% +$3.94K ﹤0.01% 4835
2019
Q4
$0 Sell
27
-1,537
-98% ﹤0.01% 5107
2019
Q3
$5K Hold
1,564
﹤0.01% 4773
2019
Q2
$6K Sell
1,564
-2,182
-58% -$8.37K ﹤0.01% 4850
2019
Q1
$15K Buy
3,746
+97
+3% +$388 ﹤0.01% 4624
2018
Q4
$14K Buy
3,649
+640
+21% +$2.46K ﹤0.01% 4529
2018
Q3
$26K Buy
+3,009
New +$26K ﹤0.01% 4414
2018
Q2
Sell
-1,547
Closed -$17K 4982
2018
Q1
$17K Buy
1,547
+1,412
+1,046% +$15.5K ﹤0.01% 4289
2017
Q4
$1K Buy
135
+134
+13,400% +$993 ﹤0.01% 4874
2017
Q3
$0 Sell
1
-55
-98% ﹤0.01% 4719
2017
Q2
$1K Sell
56
-90
-62% -$1.61K ﹤0.01% 4676
2017
Q1
$3K Sell
146
-4,200
-97% -$86.3K ﹤0.01% 4570
2016
Q4
$62K Buy
4,346
+3,077
+242% +$43.9K ﹤0.01% 4074
2016
Q3
$20K Sell
1,269
-61
-5% -$961 ﹤0.01% 4171
2016
Q2
$19K Buy
1,330
+830
+166% +$11.9K ﹤0.01% 4209
2016
Q1
$7K Buy
+500
New +$7K ﹤0.01% 4860